The performance of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced substantial volatility. Investors are now facing the consequences of rival medic